Gene expression profiling of circulating CD133+ cells of hepatocellular carcinoma patients associated with HCV infection

Conclusion KRT15 can be used to differentiate between circulating CD133+ cells from HCC group control group. However, further study may be needed to confirm on the protein level.
Source: Journal of the Egyptian National Cancer Institute - Category: Cancer & Oncology Source Type: research